RENAL HYDROCELE

RENAL HYDROCELE was reported 60 times

These drug classes are most commonly taken by patients reporting RENAL HYDROCELE:

# Drug Count
0 Vascular Endothelial Growth Factor Inhibitor [EPC] 16
1 Platinum-based Drug [EPC] 11
2 Nucleoside Metabolic Inhibitor [EPC] 10
3 Alkylating Drug [EPC] 6
4 Corticosteroid [EPC] 6
5 Kinase Inhibitor [EPC] 5
6 Microtubule Inhibitor [EPC] 5
7 Androgen Receptor Inhibitor [EPC] 2
8 CD20-directed Cytolytic Antibody [EPC] 2
9 HER2/neu Receptor Antagonist [EPC] 2
10 5-alpha Reductase Inhibitor [EPC] 1
11 Angiotensin 2 Receptor Blocker [EPC] 1
12 Anti-epileptic Agent [EPC] 1
13 Antisense Oligonucleotide [EPC] 1
14 Azole Antifungal [EPC] 1
15 Bispecific CD20-directed CD3 T Cell Engager [EPC] 1
16 CD19-directed Chimeric Antigen Receptor [EPC] 1
17 Calcineurin Inhibitor Immunosuppressant [EPC] 1
18 Dihydropyridine Calcium Channel Blocker [EPC] 1
19 Genetically-modified Autologous T Cells [EPC] 1
20 Glinide [EPC] 1
21 Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
22 Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] 1
23 Insulin Analog [EPC] 1
24 Interleukin-6 Receptor Antagonist [EPC] 1
25 Mood Stabilizer [EPC] 1
26 Opioid Agonist [EPC] 1
27 Osmotic Laxative [EPC] 1
28 Programmed Death Receptor-1 Blocking Antibody [EPC] 1
29 Radiographic Contrast Agent [EPC] 1
30 Serotonin-3 Receptor Antagonist [EPC] 1
31 Sodium-Glucose Cotransporter 2 Inhibitor [EPC] 1
32 Survival Motor Neuron-2-directed RNA Interaction [EPC] 1
33 Survival of Motor Neuron 2 Splicing Modifier [EPC] 1
34 Topoisomerase Inhibitor [EPC] 1
35 Xanthine Oxidase Inhibitor [EPC] 1
36 beta Lactamase Inhibitor [EPC] 1